Publications

Validation of Blood Pressure Measurement Using a Smartwatch in Patients With Parkinson’s Disease

Published

Front. Neurol

Date

2021.06.29

Research Areas

Health

Abstract

Objectives
We aimed to validate the accuracy of blood pressure (BP) measurement using a smartwatch in patients with Parkinson's disease (PD).
Materials and Methods
We compared 168 pairs of BP (n = 56) measurements acquired by a smartwatch (SM-R850) with those measured by a sphygmomanometer (reference device).
Results
Differences between the smartwatch BP and reference BP measurements were compared. The mean and standard deviation of the differences systolic BP (SBP) and diastolic BP (DBP), measured by smartwatch and reference device, fulfilled both criterion 1 (0.4 ± 4.6 and 1.1 ± 4.5 mm Hg for DBP and SBP, respectively) and criterion 2 (0.2 ± 2.5 and 0.9 ± 2.4 mm Hg for DBP and SBP, respectively) of the BP validation criterion of the International Organization for Standardization.
Conclusion
BP measurement using a smartwatch with a photoplethysmography sensor is an accurate and reliable method in patients with PD.

View publication

https://doi.org/10.3389/fneur.2021.650929

Back to List